Cargando…
Randomised, Placebo-Controlled, Double-Blind Study of Oral Tranexamic Acid in the Treatment of Moderate-to-Severe Melasma in an Australian Cohort
Autores principales: | Bala, Harini Rajgopal, Nguyen, Jennifer, Ross, Angelique, Wong, Celestine, Paul, Eldho, Rodrigues, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792010/ https://www.ncbi.nlm.nih.gov/pubmed/36578715 http://dx.doi.org/10.4103/ijd.ijd_120_21 |
Ejemplares similares
-
Amber photobiomodulation versus tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial
por: Galache, Thais Rodrigues, et al.
Publicado: (2023) -
A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma
por: Budamakuntla, Leelavathy, et al.
Publicado: (2013) -
Mometasone Menace in Melasma
por: Godse, Kiran V, et al.
Publicado: (2012) -
MELASMA STUDY: METHODOLOGICAL PROBLEMS
por: Panda, Saumya
Publicado: (2011) -
Topical tranexamic acid as a promising treatment for melasma
por: Ebrahimi, Bahareh, et al.
Publicado: (2014)